APLT
Applied Therapeutics, Inc.Company Information
- Company Name
- Applied Therapeutics, Inc.
- CIK
- CIK0001697532
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- APLT: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- APLT
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-12-01
- Last sale
- 2025-12-16
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 205,460
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 36,482,594
- Shares outstanding
- 145,559,604
- Ownership
- 25.06%
Earnings Market Reaction
- Filing date
- 2025-11-13
- Price on filing date
- —
- 1-month reaction
- -19.63%
- 3-month reaction
- -61.85%
Balance Sheet
Values in millions ($)| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 12 | 30 | 51 | 79 | 99 | 122 | 146 | 50 | 37 | 36 | 23 | 17 | ||||||
| Short Term Investments | - | - | - | - | - | - | - | - | - | - | - | 14 | ||||||
| Prepaid Expense And Other Assets Current | 20 | 4 | 3 | 4 | 5 | 5 | 4 | 4 | 7 | 7 | 6 | 7 | ||||||
| Assets Current | 32 | 35 | 54 | 84 | 105 | 128 | 151 | 54 | 44 | 43 | 29 | 37 | ||||||
| Operating Lease Right Of Use Asset | 2 | 3 | 3 | 3 | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Assets | 34 | 37 | 57 | 87 | 107 | 128 | 151 | 55 | 45 | 44 | 30 | 38 | ||||||
Liabilities Current | ||||||||||||||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable Current | 5 | 5 | 5 | 4 | 3 | 3 | 4 | 2 | 6 | 5 | 6 | 5 | ||||||
| Liabilities Current | 33 | 18 | 18 | 27 | 99 | 55 | 84 | 71 | 56 | 47 | 33 | 33 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Noncurrent | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 35 | 20 | 20 | 30 | 101 | 55 | 84 | 72 | 56 | 48 | 34 | 34 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Value | - | - | - | 0 | - | - | - | 0 | - | - | - | - | ||||||
| Additional Paid In Capital | 636 | 635 | 633 | 631 | 624 | 622 | 620 | 451 | 420 | 384 | 355 | 353 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Retained Earnings Accumulated Deficit | -636 | -617 | -596 | -574 | -618 | -550 | -553 | -469 | -431 | -389 | -359 | -349 | ||||||
| Stockholders Equity | -1 | 17 | 37 | 57 | 6 | 72 | 67 | -17 | -11 | -4 | -4 | 4 | ||||||
| Liabilities And Stockholders Equity | 34 | 37 | 57 | 87 | 107 | 128 | 151 | 55 | 45 | 44 | 30 | 38 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 144 | 142 | 142 | 137 | 116 | 115 | 114 | 85 | 77 | 62 | 48 | 48 | ||||||
| Shares Outstanding | 144 | 142 | 142 | 137 | 116 | 115 | 114 | 85 | 77 | 62 | 48 | 48 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialApplied Therapeutics, Inc. (APLT) — SEC Financial Statements & Analysis
Applied Therapeutics, Inc. (APLT) is a pharmaceutical preparations company, incorporated in DE. Applied Therapeutics, Inc. trades on Nasdaq as: APLT. Applied Therapeutics, Inc. (APLT)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-13. Based on that filing, On profitability, Applied Therapeutics, Inc. posts an operating margin of -9949.85%, a net margin of -1833.97%, a Return on Equity (ROE) of -680.47%, and a Return on Assets (ROA) of -25.74%. Per share, it reports EPS of $-0.12, diluted EPS of $-0.12, free cash flow per share of $-0.60, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -592.04% year-over-year, net income growth of -90.32% year-over-year, and EPS growth of -90.40% year-over-year. On the balance sheet, it maintains a current ratio of 0.96x, a quick ratio of 0.36x, working capital of $-1.25M, a debt-to-equity ratio of -62.27x, a debt ratio of 1.02, an interest coverage ratio of -47.04x, free cash flow of $-86.85M (TTM), and net debt of $-11.95M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-0.12
- ROE TTM
- -680.47%
- ROA TTM
- -25.74%
- Debt To Equity
- -62.27x
- Free Cash Flow TTM
- $-86.85M
- Net Revenue TTM Growth 1Y
- -592.04%
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Applied Therapeutics, Inc. in?
Applied Therapeutics, Inc. (APLT) operates in the Pharmaceutical Preparations industry.
What exchange does APLT trade on?
Applied Therapeutics, Inc. (APLT) trades on the Nasdaq.
Where is Applied Therapeutics, Inc. incorporated?
Applied Therapeutics, Inc. is incorporated in DE.
When was Applied Therapeutics, Inc. (APLT)'s most recent SEC filing?
Applied Therapeutics, Inc. (APLT)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-13.
What is APLT's EPS (earnings per share)?
Applied Therapeutics, Inc. (APLT)'s trailing twelve month EPS is $-0.12 as of 2025-09-30.
What is APLT's ROE (return on equity)?
Applied Therapeutics, Inc. (APLT)'s trailing twelve month Return on Equity (ROE) is -680.47% as of 2025-09-30.
What is APLT's ROA (return on assets)?
Applied Therapeutics, Inc. (APLT)'s trailing twelve month Return on Assets (ROA) is -25.74% as of 2025-09-30.